Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of TY-0201 Transdermal Bisoprolol in Chronic Atrial Fibrillation
jRCT2080222737Phase 3Completed
- Sponsor
- TOA EIYO
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bisoprolol in Atrial fibrillation (AFib) (2 arms), sponsored by TOA EIYO. Primary endpoint: Heart rate reduction non-inferiority. Started Feb 2015; status: completed.
02
Drugs
bisoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCT2080222737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222737.